Related Experiment Video
Updated: Jul 4, 2026
11:31
High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
Published on: August 16, 2019
Parameters influencing antigen-specific immunotherapy for type 1 diabetes
1Department of Microbiology, University of North Carolina at Chapel Hill, Mary Ellen Jones Bldg., Room 635, Campus Box 7290, Chapel Hill, NC 27599-7290, USA.
Immunologic Research
|June 11, 2008
Summary
Type 1 diabetes immunotherapy uses beta cell antigens to target harmful T cells. This approach aims to prevent and treat type 1 diabetes by inducing tolerance to specific antigens.
Area of Science:
- Immunology
- Endocrinology
- Autoimmune Diseases
Background:
- Type 1 diabetes is an autoimmune condition where T cells destroy insulin-producing beta cells.
- Current treatments often have broad immunosuppressive effects.
- Antigen-based immunotherapy offers a targeted approach to restore immune tolerance.
Purpose of the Study:
- To explore the efficacy of beta cell antigen vaccination for type 1 diabetes.
- To define key parameters influencing the success of antigen-based immunotherapy.
- To advance prevention and treatment strategies for type 1 diabetes.
Main Methods:
- Review of experimental data on beta cell antigen administration.
- Analysis of immune responses in preclinical models.
- Identification of factors affecting therapeutic outcomes.
Main Results:
- Specific parameters were identified that significantly impact the efficacy of beta cell antigen vaccination.
- The approach demonstrated potential for selective T cell tolerization.
- Understanding these parameters is crucial for optimizing treatment.
Conclusions:
- Beta cell antigen vaccination is a promising strategy for type 1 diabetes.
- Further research into optimal antigen delivery and formulation is warranted.
- This immunotherapy approach holds potential for preventing and treating type 1 diabetes.
Related Concept Videos
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:40Cell-mediated Immune Responses
Overview
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.